Introducing Diazyme’s Blood-Based Neurological Biomarker Panel for Advanced Research
30th Apr 2025
In response to the rising global demand for innovative and accessible tools in neurodegenerative disease research, Diazyme is excited to unveil a new panel of six blood-based neurological biomarker assays. Developed exclusively for research use, these assays are optimized for use on the DZ-Lite™ i2000, a fully automated chemiluminescence analyzer with very high sensitivities.
This cutting-ed
…